Losartan Potassium Tablets

  • 网络氯沙坦钾片
Losartan Potassium TabletsLosartan Potassium Tablets
  1. METHODS The effects of diluents , disintegrants , bonding agents and coating process on the dissolution profile of the losartan potassium tablets were studied .

    方法:分别考察稀释剂、崩解剂、黏合剂及包衣对氯沙坦钾片溶出度的影响。

  2. As age increase , with the absence of drug intervention , the model group showed a clear upward trend in blood pressure , positive drug losartan potassium tablets can reverse this trend , and its antihypertensive effect is better than medicine groups .

    随着SHR周龄的上升,在无药物干预的情况下,模型组血压呈明显上升趋势,阳性药物氯沙坦钾片可以扭转此趋势,且其降压效果优于中药各组。

  3. CONCLUSION Capillary zone electrophoresis may be an accurate and simple method for the determination of the two components in compound losartan potassium tablets .

    结论本实验结果表明,用毛细管区带电泳(CZE)法进行氯沙坦钾复方制剂中氢氯噻嗪、氯沙坦钾两种成分的含量测定,方法准确、可靠,简便易行。

  4. Conclusion Ginaton injection solution combined with losartan potassium tablets can effectively lower DN patients ' Microalbuminuria and Blood urea nitrogen , which has clinical importance to the protection of DN patients ' kidney function .

    结论金纳多注射液和科素亚联用能有效降低DN患者UMA及BuN,对DN患者保护肾功能有一定的临床疗效。

  5. Methods One hundred patients with diabetic nephropathy phase ⅳ were divided into two groups randomly and were treated with Losartan Potassium tablets or Lotensin for eight weeks , and the levels of albuminuria for 24 hours were measured both before and after eight weeks treatment .

    方法100例糖尿病肾病Ⅳ期患者随机分为2组,分别应用科素亚、洛汀新治疗8周,检测并对比实验前后24h尿蛋白总量。

  6. Isolation of Related Compounds and Determination of Losartan Potassium in COZAAR Tablets by RP-HPLC

    RP-HPLC法分离科素亚片中芦沙坦钾有关物质及含量测定

  7. Comparison study of telmisartan / hydrochlorothiazide tablets and losartan potassium / hydrochlorothiazide tablets on antihypertensive efficacy and reversing vascular endothelial dysfunction

    替米沙坦/氢氯噻嗪片和氯沙坦钾/氢氯噻嗪片的降压疗效和对血管内皮功能的影响研究

  8. Relative Bioavailability of Losartan Tablet in Healthy Volunteers Study on the formulation of losartan potassium tablets

    国产氯沙坦钾片的生物等效性研究氯沙坦钾片剂的处方设计及其制备